Clonidine
Back to searchMolecule Structure
Scientific Name
Clonidine
Description of the Drug
Clonidine is an alpha-2 adrenergic agonist used to treat hypertension and severe cancer pain, among other conditions, and to treat withdrawal symptoms from various substances. It is also used to aid in the diagnosis of pheochromocytoma and to prevent migraines.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00575
http://www.drugbank.ca/drugs/DB00575
Brand Name(s)
Catapres, Catapres-tts-1, Catapres-tts-2, Catapres-tts-3, Clonidine, Nexiclon xr
Company Owner(s)
Xiamen Lp Pharmacuetical Co Ltd, Jubilant Generics Ltd, Sun Pharmaceutical Industries Inc, Watson Laboratories Inc, American Regent Inc, Anchen Pharmaceuticals Inc, Mylan Pharmaceuticals Inc, Xgen Pharmaceuticals Djb Inc, Zydus Pharmaceuticals Usa Inc, Aurolife Pharma Llc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Adrenergic receptor alpha-2 | PROTEIN FAMILY | AGONIST | CHEMBL2095158 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL5982 | |||||
| PharmGKB | PA449051 | |||||
| Human Metabolome Database | HMDB0014714 | |||||
| DrugBank | DB00575 | |||||
| PubChem: Thomson Pharma | 15172366 | 14822899 | ||||
| PubChem | 2803 | |||||
| Mcule | MCULE-5017779690 | |||||
| LINCS | LSM-4223 | |||||
| Nikkaji | J9.618K | |||||
| PDBe | CLU | |||||
| BindingDB | 50016897 | 50225285 | 14062 | |||
| EPA CompTox Dashboard | DTXSID6022846 | |||||
| DrugCentral | 704 | |||||
| Brenda | 13274 | |||||
| ChemicalBook | CB6505769 | |||||
| Guide to Pharmacology | 516 | |||||
| rxnorm | CLONIDINE HYDROCHLORIDE | CLORPRES | KAPVAY | DURACLON | CATAPRES | CLONIDINE |
| ChEBI | 3757 | 46632 | ||||
| ZINC | ZINC000000896484 |
